[
1. https://www.who.int/srilanka/news/detail/16-10-2021-post-covid-19-condition
]Search in Google Scholar
[
2. Nalbandian, A. et. al. Post-acute COVID-19 syndrome. Nature Medicine. Vol. 27, 601-615 (2021)
]Search in Google Scholar
[
3. Leung, T.Y.M.; Chan, A.Y.L.; Chan, E.W.; Chan, V.K.Y.; Chui, C.S.L.; Cowling, B.J.; Gao, L.; Ge, M.Q.; Hung, I.F.N.; Ip, M.S.M.; et al. Short- and potential long-term adverse health outcomes of Covid-19: A rapid review. Emerg. Microbes Infect. 2020, 9, 2190–2199.
]Search in Google Scholar
[
4. Vitiello, A.; Ferrara, F. Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19. Life Sci. 2020, 262, 118510.
]Search in Google Scholar
[
5. Andrade, B.S.; Rangel, F.S.; Santos, N.O.; Freitas, A.D.S.; Soares, W.R.A.; Siqueira, S.; Barh, D.; Goes-Neto, A.; Birbrair, A.; Azevedo, V.A.C. Repurposing approved drugs for guiding Covid-19 prophylaxis: A systematic review. Front. Pharmacol. 2020, 11, 590598.
]Search in Google Scholar
[
6. Jin, Y.; Ji, W.; Yang, H.; Chen, S.; Zhang, W.; Duan, G. Endothelial activation and dysfunction in Covid-19: From basic mechanisms to potential therapeutic approaches. Signal. Transduct. Target. Ther. 2020, 5, 293.
]Search in Google Scholar
[
7. Giustino, G.; Pinney, S.P.; Lala, A.; Reddy, V.Y.; Johnston-Cox, H.A.; Mechanick, J.I.; Halperin, J.L.; Fuster, V. Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: Jacc focus seminar. J. Am. Coll. Cardiol. 2020, 76, 2011–2023.
]Search in Google Scholar
[
8. 14. Teuwen, L.A.; Geldhof, V.; Pasut, A.; Carmeliet, P. Covid-19: The vasculature unleashed. Nat. Rev. Immunol. 2020, 20, 389–391.
]Search in Google Scholar
[
9. 15. Grosse, C.; Grosse, A.; Salzer, H.J.F.; Dunser, M.W.; Motz, R.; Langer, R. Analysis of cardiopulmonary findings in Covid-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Cardiovasc. Pathol. 2020, 49, 107263.
]Search in Google Scholar
[
10. Karlsson AC, Humbert M, Buggert M. The known unknowns of T cell immunity to COVID. Sci Immunol. 2020;5(53):19.10.1126/sciimmunol.abe8063
]Search in Google Scholar
[
11. Zuo Y, Estes SK, Ali RA, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. SciTransl Med. 2020;12:eabd3876.10.1126/scitranslmed.abd3876
]Search in Google Scholar
[
12. Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;(6515):370.
]Search in Google Scholar
[
13. Gao ZW, Zhang H, Liu C, et al. Autoantibodies in COVID- 19: frequency and function. Autoimmun Rev. 2021;20(3): 102754.10.1016/j.autrev.2021.102754
]Search in Google Scholar
[
14. Vlachoyiannopoulos PG, Magira E, Alexopoulos H, et al. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis. 2020;79(12):1661–1663.10.1136/annrheumdis-2020-218009
]Search in Google Scholar
[
15. Zhou Y, Han T, Chen J, et al. Clinical and autoimmune characteristics of severe and critical cases of COVID. Clin Transl Sci. 2020;13(6):1077–1086.10.1111/cts.12805
]Search in Google Scholar
[
16. Elkon K, Casali P. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol. 2008;4(9): 491–498.10.1038/ncprheum0895
]Search in Google Scholar
[
17. Amato MK, Hennessy C, Shah K, et al. Multisystem inflammatory syndrome in an adult. J Emerg Med. 2021. DOI:10.1016/j.jemermed.2021.02.007
]Open DOISearch in Google Scholar
[
18. Belot A, Antona D, Renolleau S, et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill. 2020;25(22):2001010.10.2807/1560-7917.ES.2020.25.22.2001010
]Search in Google Scholar
[
19. Morris SB, Schwartz NG, Patel P, et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection – United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69(40):1450–1456.10.15585/mmwr.mm6940e1
]Search in Google Scholar
[
20. Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369:m2094.10.1136/bmj.m2094
]Search in Google Scholar
[
21. Whittaker E, Bamford A, Kenny J, et al. Clinical charac teristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3): 259–26910.1001/jama.2020.10369
]Search in Google Scholar
[
22. Zhao YM, Shang YM, Song WB, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.10.1016/j.eclinm.2020.100463
]Search in Google Scholar
[
23. Marvisi M, Ferrozzi F, Balzarini L, et al. First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: Factors predicting fibrotic evolution. Int J Infect Dis. 2020;99:485-488.10.1016/j.ijid.2020.08.054
]Search in Google Scholar
[
24. Liao B, Liu Z, Tang L, et al. Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19. Int J Med Sci. 2021;18(1):29-41.10.7150/ijms.49728
]Search in Google Scholar
[
25. Raman B, Cassar MP, Tunnicliffe EM, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. Eclinical Medicine. 2021;31:100683.10.1016/j.eclinm.2020.100683
]Search in Google Scholar
[
26. Mandal S, Barnett J, Brill SE, et al. Long-COVID’: a crosssectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID. Thorax. 2021;76(4):396–39810.1136/thoraxjnl-2020-215818
]Search in Google Scholar
[
27. Liang L, Yang B, Jiang N, et al. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J Korean Med Sci. 2020;35(47):e41810.3346/jkms.2020.35.e418
]Search in Google Scholar
[
28. Vlachoyiannopoulos PG, Magira E, Alexopoulos H, et al. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis. 2020;79:1661-1663. doi: 10.1136/annrheumdis-2020-218009.
]Open DOISearch in Google Scholar
[
29. Vlachoyiannopoulos PG, Magira E, Alexopoulos H, et al. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis 2020;79:1661-3.10.1136/annrheumdis-2020-218009
]Search in Google Scholar
[
30. Perrot L, Hemon M, Busnel J-M, et al. First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection. Lancet Rheumatol 2021; 3:e6–8.doi:10.1016/S2665-9913(20)30396-9
]Open DOISearch in Google Scholar
[
31. Liao B, Liu Z, Tang L, et al. Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19. Int J Med Sci. 2021;18(1):29–41. doi: 10.7150/ijms.49728.773896033390771
]Open DOISearch in Google Scholar
[
32. Marvisi M, Ferrozzi F, Balzarini L, et al. First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: factors predicting fibrotic evolution. Int J Infect Dis. 2020;99:485–488.10.1016/j.ijid.2020.08.054
]Search in Google Scholar
[
33. Moreno-Pérez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021;82(3):378–383. doi: 10.1016/j.jinf.2021.01.004.780252333450302
]Open DOISearch in Google Scholar
